EDIT: Editas Medicine Inc
EDIT exchange rate has changed by -2.87% for today. During the day, the instrument was traded at a low of 2.00 and at a high of 2.11.
Follow Editas Medicine Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
EDIT News
- Editas (EDIT) Down 8.3% Since Last Earnings Report: Can It Rebound?
- NVO Stock Down as Rybelsus Misses Goals in 2 Alzheimer's Studies
- Biogen Inks Research Deal With Dayra to Boost Immunology Pipeline
- AZN Wins FDA Nod for Expanded Use of Rare Disease Drug, Koselugo
- COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know
- Top 3 Genomics Stocks to Consider for Your Portfolio
- Is Alto Neuroscience, Inc. (ANRO) Outperforming Other Medical Stocks This Year?
- Editas Q3 Loss Narrower Than Expected, Revenues Increase Y/Y
- Clear Street raises Editas Medicine stock price target to $4.60 on extended cash runway
- Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates
- Editas Medicine earnings beat by $0.02, revenue topped estimates
- Gyre Therapeutics, Inc. (GYRE) Q3 Earnings Surpass Estimates
- Janux Therapeutics, Inc. (JANX) Reports Q3 Loss, Tops Revenue Estimates
- Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates
- Editas Medicine at Chardan’s Conference: Gene Editing Insights
- Editas Medicine: Three Strikes And It's Out, Or Third Time’s The Charm?
- Editas Medicine reports 90% LDL-C reduction in preclinical studies
- Editas Medicine to present CRISPR cholesterol research at ESGCT
- Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report?
- Editas Medicine stock maintains Buy rating at H.C. Wainwright on EDIT-401 progress
- Editas Nominates EDIT-401 as Lead In Vivo Therapy for High Cholesterol
- Wells Fargo raises Editas Medicine stock price target to $4 on EDIT-401 data
- Editas Medicine, Inc. (EDIT) Lead In Vivo Development Candidate Webinar Call (NASDAQ:EDIT)
- Satellos Bioscience: Promising Novel Treatment For Duchenne Muscular Dystrophy (TSX:MSCL:CA)
Trading Applications for EDIT
Frequently Asked Questions
What is EDIT stock price today?
Editas Medicine Inc stock is priced at 2.03 today. It trades within 2.00 - 2.11, yesterday's close was 2.09, and trading volume reached 3142. The live price chart of EDIT shows these updates.
Does Editas Medicine Inc stock pay dividends?
Editas Medicine Inc is currently valued at 2.03. Dividend policy depends on the company, while investors also watch 61.11% and USD. View the chart live to track EDIT movements.
How to buy EDIT stock?
You can buy Editas Medicine Inc shares at the current price of 2.03. Orders are usually placed near 2.03 or 2.33, while 3142 and -2.87% show market activity. Follow EDIT updates on the live chart today.
How to invest into EDIT stock?
Investing in Editas Medicine Inc involves considering the yearly range 0.91 - 4.54 and current price 2.03. Many compare -1.46% and -18.15% before placing orders at 2.03 or 2.33. Explore the EDIT price chart live with daily changes.
What are Editas Medicine Inc stock highest prices?
The highest price of Editas Medicine Inc in the past year was 4.54. Within 0.91 - 4.54, the stock fluctuated notably, and comparing with 2.09 helps spot resistance levels. Track Editas Medicine Inc performance using the live chart.
What are Editas Medicine Inc stock lowest prices?
The lowest price of Editas Medicine Inc (EDIT) over the year was 0.91. Comparing it with the current 2.03 and 0.91 - 4.54 shows potential long-term entry points. Watch EDIT moves on the chart live for more details.
When did EDIT stock split?
Editas Medicine Inc has gone through stock splits historically. These changes are visible in , 2.09, and 61.11% after corporate actions.
- Previous Close
- 2.09
- Open
- 2.09
- Bid
- 2.03
- Ask
- 2.33
- Low
- 2.00
- High
- 2.11
- Volume
- 3.142 K
- Daily Change
- -2.87%
- Month Change
- -1.46%
- 6 Months Change
- -18.15%
- Year Change
- 61.11%
- Act
- Fcst
- Prev